Clinical Trials Directory

Trials / Completed

CompletedNCT03896243

Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

Status
Completed
Phase
Study type
Observational
Enrollment
102 (actual)
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Investigators would like to see the amh values after uterine artery ligation

Detailed description

Group/cohort: Uterine artery ligation (UAL) Investigators would like to invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. Participants would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC) Control Group: Investigators would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication. Participants would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUterine artery ligation (UAL)Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Timeline

Start date
2018-01-01
Primary completion
2019-01-01
Completion
2019-02-01
First posted
2019-03-29
Last updated
2019-03-29

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03896243. Inclusion in this directory is not an endorsement.